SCHEMBL3788143

SCHEMBL3788143

c1ccn2nc(-c3nccs3)cc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDPK1 O15530 1/20 0.47
▸ RAB9A P51151 2/20 0.43
▸ KDR P35968 1/20 0.41
▸ MIF P14174 1/20 0.40
▸ ADRA2A P08913 1/20 0.39
▸ ADRA1A P35348 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.38
▸ HSP90AA1 P07900 1/20 0.38
▸ SYK P43405 3/20 0.37
▸ MAP4K4 O95819 1/20 0.37
▸ ABL1 P00519 1/20 0.37
▸ MAPK8 P45983 1/20 0.37
▸ CSNK1A1 P48729 1/20 0.37
▸ CDK7 P50613 1/20 0.37
▸ TYRO3 Q06418 1/20 0.37
▸ LRRK2 Q5S007 1/20 0.37
▸ AURKB Q96GD4 1/20 0.37
▸ CLK4 Q9HAZ1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2202066 0.76 APOBEC3A (0.47) PDPK1RAB9AKDRADRA2AADRA1A
SCHEMBL29846190 0.76 PDPK1 (0.41) PDPK1RAB9AKDRHSP90AA1SYK
SCHEMBL16863346 0.75 KDM4E (0.43) RAB9AMIFKDM4EHSD17B10HRH3
SCHEMBL11322916 0.73 KDM4E (0.50) RAB9AMIFKDM4EHSD17B10HRH3
SCHEMBL29846161 0.73 MIF (0.36) RAB9AMIFKDM4EHSD17B10HRH3
SCHEMBL5953401 0.72 HRH3 (0.51) RAB9AMIFKDM4EHSD17B10HRH3
SCHEMBL31024123 0.70 HRH3 (0.47) MIFKDM4EHRH3MAP4K4ABL1
SCHEMBL7169834 0.69 PDPK1 (0.51) PDPK1RAB9AKDRADRA2AADRA1A
SCHEMBL16265168 0.68 DYRK1A (0.54) PDPK1RAB9AKDRADRA2AADRA1A
SCHEMBL3957689 0.67 MAP4K4 (0.41) RAB9AMIFKDM4EHSD17B10HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025143152-A1 THIAZOLYL-PYRAZOLO[1,5-A]PYRIDINE COMPOUND AND USE THEREOF AS MYLK4 INHIBITOR 全薬工業株式会社 2025-07-03 — — WO disclosed
EP-2391619-A1 HETEROARYLS AND THEIR USE AS PI3K INHIBITORS Millennium Pharmaceuticals, Inc. (US) 2011-12-07 — — EP disclosed
WO-2010090716-A1 HETEROARYLS AND THEIR USE AS PI3K INHIBITORS MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-08-12 — — WO disclosed
Send feedback